Highlights from the 2021 AAN Annual Meeting

The Latest in Parkinson’s Research from AAN 2021 The American Academy of Neurology (AAN) is the preeminent professional association...see more for neurologists in the US dedicated to supporting and improving the profession of neurology. Every year, AAN holds an annual conference at which new data on all aspects of neurology, including Parkinson’s disease (PD), is presented. […]

Read More

Where are they now? APDA’s research success continued

Q & A with APDA research grant recipients Since 1961, APDA has been a funding partner in many major...see more scientific breakthroughs and has awarded more than $51 million in research grants to date. APDA funds individual research grants and fellowships to scientists performing innovative Parkinson’s disease (PD) research. Grants are awarded through a competitive application […]

Read More

Neuroinflammation in Parkinson’s disease: An Interview with ADPA Researcher, Dr. Edward Griffin

Dr. Edward Griffin researches the relationship between neuroinflammation and Parkinson’s disease Today we introduce you to Dr. Edward Griffin, a...see more post-doctoral fellow at the University of Alabama at Birmingham. He is the recipient of a 2019-2020 APDA Post-doctoral fellowship and is currently studying the role of inflammation in the development of Parkinson’s disease (PD). We asked […]

Read More

PD and the microbiome

What is the microbiome? The human gut harbors trillions of micro-organisms referred to collectively as the microbiome. Current understanding...see more is that the microbiome provides a number of benefits to the human including help with digestion of food, help with warding off harmful microorganisms, aid in the absorption of particular nutrients, and creation of needed vitamins. […]

Read More

Therapies for non-motor symptoms of Parkinson’s disease in clinical trials

The pipeline for Parkinson’s disease (PD) medications is extremely crowded these days, with multiple medications at various stages of...see more research and development. Currently most of the approved medications for PD address the motor symptoms of PD – tremor, slowness, stiffness, and walking difficulties. Medications are also available to help people overcome OFF time or improve […]

Read More

Parkinson’s Partners: Introducing Medical Students to Parkinson’s disease

As all of you know very well, Parkinson’s disease (PD) is a complex disorder that affects so many parts...see more of a person’s life. In order for physicians to fully understand the impact the disease has on people with PD, it is not enough to learn the science and medicine of the condition. But how is […]

Read More

Where are they now? APDA’s research success

Q&A with APDA research grant recipients   Since 1961, APDA has been a funding partner in many major scientific...see more breakthroughs and has awarded more than $49 million in research grants to date. APDA funds individual research grants and fellowships to scientists performing innovative Parkinson’s disease (PD) research. Grants are awarded through a competitive application process […]

Read More

Is a vaccine for Parkinson’s disease possible?

As the world awaits an effective vaccine for SARS-CoV2 (the virus that causes COVID-19), vaccines and vaccination are at...see more the front and center of the news and in our minds. A vaccine is a substance that is introduced into the body in order to stimulate the immune system to provide protection against a particular disease. […]

Read More

Highlights From The Movement Disorders Society Virtual Congress 2020

Every year the International Parkinson and Movement Disorder Society (MDS) holds a conference and every year APDA is there,...see more learning about the newest research and sharing our resources with the wider PD community. The MDS Congress is the preeminent gathering of medical professionals from around the world who are dedicated to Parkinson’s disease (PD) and […]

Read More